Michael Saylor’s Strategy Inc. MSTR is increasingly relying on STRC to keep buying Bitcoin BTC, but the math behind the ...

SAI created its Regenerating Together program to make global regenerative agriculture standards adaptable at the local level.

Novo Nordisk is running other phase 2 trials of the drug, including the 8212-Preserved study in heart failure with preserved ...

Swisspod, a Swiss-American company co-founded by Romanian entrepreneur Denis Tudor, announced that it set a new hyperloop ...

In Wuhan, patients underwent echocardiography irrespective of the severity of COVID-19, and this cohort included patients who did not require intensive care. In London, echocardiography was performed ...

Results from the first randomised trial evaluating microRNA inhibition in heart failure were presented today at Heart Failure 2026.

Cytokinetics (NASDAQ:CYTK) reported positive top-line results from ACACIA-HCM, a pivotal Phase 3 trial evaluating aficamten in patients with symptomatic non-obstructive hypertrophic cardiomyopathy ...

SOUTH SAN FRANCISCO, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) reported a management ...

Topline data from the ACACIA-HCM study reveal that the cardiac myosin inhibitor aficamten met all primary and key secondary endpoints, offering a potential new treatment pathway for patients with ...

A ₹40 crore retirement corpus may sound excessive, but for urban Indians, rising inflation and longer lifespans are changing ...

For healthcare investors, few catalysts matter more than success in a Phase III clinical trial, the last major hurdle before ...

Treatment patterns of patients with glioblastoma multiforme in the real-world setting in a developing country. 3 mg/kg IV Q2W x 12 doses; then 480 mg IV Q4W x 7 doses 1 mg/kg IV Q6W x 4 doses 8 Gy x 3 ...